Toxicology of Quinone-Thioethers

References

• Thompson R. H. Naturally Occurring Quinones. Academic Press, London 1971
   Google Scholar
• Monks T. J., Walker S. E., Flynn L. M., Conti C. J., DiGiovanni J. Epidermal ornithine decarboxylase induction and mouse skin tumor promotion by quinones. Carcinogenesis 1990; 11: 1795
   PubMedGoogle Scholar
• Ames B. N. Dietary carcinogens and anticarcinogens. Science 1983; 221: 1256
   PubMed Web of Science ®Google Scholar
• Chesis P. L., Levin D. E., Smith M. T., Ernster L., Ames B. N. Mutagenicity of quinones: pathways of metabolic activation and detoxification. Proc. Natl. Acad. Sci. U. S. A. 1984; 81: 1696
   PubMed Web of Science ®Google Scholar
• Schuetzle D., Lee S. -C., Prater T. J., Tejada S. B. Polynuclear aromatic hydrocarbon (PAH) derivatives in mutagenic fractions of diesel particulate extracts. Int. J. Environ. Anal. Chem. 1981; 9: 93
   PubMed Web of Science ®Google Scholar
• Schuetzle D. Sampling of vehicle emissions for chemical analysis and biological testing, Environ. Health Perspect 1983; 47: 65
   Google Scholar
• Stanford Research Institute (SRI) Database. 1984
   Google Scholar
• Raff R., Ettling B. V. Hydroquinone, resorcinol and pyrocatechol, in. Encyclopedia of Chemical Technology. John Wiley & Sons, New York 1966; Vol. 11: 462
   Google Scholar
• Final report on the safety assessment of hydroquinone and pyrocatechol. J. Am. Coll. Toxicol. 1986; 5: 123
   Google Scholar
• IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans: tobacco smoking. 1986; 38, IARC, Lyon, France
   Google Scholar
• Parke D. V., Williams R. T. Studies in detoxification. The metabolism of benzene containing 14C benzene. Biochem. J. 1953; 54: 231
   PubMed Web of Science ®Google Scholar
• Smith M. T., Evans C. G., Thor H., Orrenius S. Quinone-induced oxidative injury to cells and tissues, in. Oxidative Stress, H. Sies. Academic Press, London 1985; 91
   Google Scholar
• Jocelyn P. C. Biochemistry of the SH Group. Academic Press, London 1972
   Google Scholar
• Finley K. T. The addition and substitution chemistry of quinones, in. The Chemistry of the Quinonoid Compounds, Part 2, S. Patai. John Wiley & Sons, New York 1974; 877
   Google Scholar
• Reed D. J., Meredith M. J. Cellular defense mechanisms against reactive metabolites, in. Bioactivation of Foreign Compounds, M. W. Anders. Academic Press, New York 1985; 71
   Google Scholar
• Friedmann E., Marrian D. H., Simon-Ruess I. Sulfhydryl addition compounds of some quinones and related substances and their action on the growth of normal cells. Br. J. Pharmacol. 1948; 3: 335
   Google Scholar
• Schubert M. The interaction of thiols and quinones. J. Am. Chem. Soc. 1947; 69: 712
   PubMedGoogle Scholar
• Luvalle J. E. The reaction of quinone and sulfite. I. Intermediates. J. Am. Chem. Soc. 1952; 74: 2970
   Google Scholar
• Burton H., David S. B. Addition reactions of quinones. I. The reaction of cysteine and thiourea and its derivatives with some quinones. J. Chem. Soc. 1952; 2193
   Google Scholar
• Bongartz J. On the reactions of aldehydes, ketones and ketoacids with thioglycolic acid. Ber. Dtsch. Chem. Ges. 1888; 21: 478
   Google Scholar
• Posner T. Ueber die Constitution der Phenochi-none, Thiophenochinone und Chinone. Ein Versuch zur einheitlichen Erklarung der Additionsvorgange beim chinon. Justus Liebigs Ann. Chem. 1904; 336: 85
   Google Scholar
• Snell J. M., Weissberger A. The reaction of thiol compounds with quinones. J. Am. Chem. Soc. 1939; 61: 450
   Google Scholar
• Fieser L. F., Turner R. B. The addition of sulfhydryl derivatives to 2-methyl-1, 4-naphthoquinone. J. Am. Chem. Soc. 1947; 69: 2335
   PubMedGoogle Scholar
• Nickerson J. W., Falcone G., Strauss G. Studies on quinone-thioethers. I. Mechanism of formation of thiodone. Biochemistry 1963; 2: 537
   PubMed Web of Science ®Google Scholar
• Marcus S. Antibacterial activity of fuscin [addendum]. Biochem. J. 1948; 43: 528
   PubMedGoogle Scholar
• Wilson I., Wardman P., Lin T., Sartorelli A. C. One-electron reduction of 2- and 6-methyl-1, 4-naphthoquinone bioreductive alkylating agents. J. Med. Chem. 1986; 29: 1381
   PubMedGoogle Scholar
• Buffinton G. D., Ollinger K., Brunmark A., Cadenas E. DT-diaphorase-catalysed reduction of 1,4-naphthoquinone derivatives and gluta-thionyl-quinone conjugates. Biochem. J. 1989; 257: 561
   PubMed Web of Science ®Google Scholar
• Hansson C., Rorsman H., Rosengren E. 5–5-CysteinyIdopa as a substrate for tyrosinase. Acta Dermatol. 1980; 60: 399
   Google Scholar
• Ito S., Novellino E., Chioccara F., Misuraca G., Prota G. Co-polymerization of dopa and cysteinyldopa in melanogenesis. in vitro, Experientia 1980; 36: 822
   PubMedGoogle Scholar
• Brown E. R., Finley K. T., Reeves R. L. Steric effects of vicinal substituents on redox equilibria in quinonoid compounds. J. Org. Chem. 1971; 36: 2849
   Google Scholar
• Miyata N., Miyahara M., Kamiya S. Chemical studies related to the mechanism of action of 3-terr-butyl-4-hydroxyanisole. Proc. 4th Biennial Meet. Soc. Free Rad. Res. 1988; 214
   Google Scholar
• Monks T. J., Lau S. S. Glutathione, γ-glutamyl transpeptidase and the mercapturic acid pathway as modulators of 2-bromohydroquinone oxidation. Toxicol. Appl. Pharmacol. 1990; 103: 557
   PubMed Web of Science ®Google Scholar
• Lau S. S., Monks T. J. Glutathione conjugation as a mechanism of targeting latent quinones to the kidney, in. Biological Reactive Intermediates IV. Molecular and Cellular Effects and Human Impact, C. M. Witmer, R. R. Snyder, D. J. Jollow, G. F. Kalf, J. J. Kocsis, I. G. Sipes. Plenum, New York 1991; 457
   Google Scholar
• Bray H. G., Franklin T. J., James S. P. The formation of mercapturic acids. 3.N-Acetylation of 5-substituted cysteines in the rabbit, rat and guinea pig. Biochem. J. 1959; 73: 465
   PubMed Web of Science ®Google Scholar
• Duffel M. W., Jakoby W. B. CysteineS-conjugateN-acetyltransferase from rat kidney microsomes. Mol. Pharmacol. 1982; 21: 444
   PubMed Web of Science ®Google Scholar
• Suzuki S., Tateishi M. Purification and characterization of a rat liver enzyme catalysingN-deacetylation of mercapturic acid conjugates. Drug Me-tab. Dispos. 1981; 9: 573
   PubMed Web of Science ®Google Scholar
• Rotman A., Daly J. W., Creveling C. R. Oxygen-dependent reaction of 6-hydroxy-dopamine, 5,6-dihydroxytryptamine, and related compounds with proteins in vitro: a model for cytotoxicity. Mol. Pharmacol 1976; 12: 887
   PubMedGoogle Scholar
• Eyer P., Lierheimer E., Strosar M. Site and mechanism of covalent binding of 4-dimethylaminophenol to human hemoglobin, and its implications to the functional properties. Mol. Pharmacol. 1983; 24: 282
   PubMedGoogle Scholar
• Huggett A., Blair I. A. The mechanism of paracetamol-induced hapatotoxicity: implications for therapy. Hum. Toxicol. 1983; 2: 399
   PubMedGoogle Scholar
• Streeter A. J., Harvison P. J., Nelson S. D., Baillie T. A. Cross-linking of protein molecules by the reactive metabolism of arctaminophen. N, J. J. Kocsis, D. J. Jollow, C. M. Witmer, J. O. Nelson, R. Synder. Plenum, New York 1985; 727, acetyl-p-benzoquinone imine, and related quinoid compounds, inBiological Reactive Intermediates III: Mechanism of Action in Animal Models and Human Disease
   Google Scholar
• Wefers H., Sies H. Hepatic low-level chemiluminescence during redox cycling of menadione and the menadione-glutathione conjugate: relation to glutathione and NAD(P)H:quinone reductase (DT-dia-phorase) activity. Arch. Biochem. Biophys. 1983; 224: 568
   PubMed Web of Science ®Google Scholar
• Brown P. C., Dulik D. M., Jones T. W. The toxicity of menadione (2-methyl-1, 4-naphthoquinone) and two thioether conjugates studied with isolated renal epithelial cells. Arch. Biochem. Biophys. 1991; 285: 187
   PubMed Web of Science ®Google Scholar
• Sies H., Akerboom T., Ishikawa T. Glutathione conjugates: transport from the cell and intracellular effects, in. Glutathione Centennial. Molecular Perspectives and Clinical Implications, N. Taniguchi, T. Higashi, Y. Sakamoto, A. Meister. Academic Press, New York 1989; 357
   Google Scholar
• Sies H. Intracellular effects of glutathione conjugates and their transport from the cell, in. Glutathione Conjugation Mechanisms and Biological Significance, H. Sies, B. Ketterer. Academic Press, New York 1988; 176
   Google Scholar
• Ernster L. DT-Diaphorase. Methods Enzymol. 1967; 10: 309
   Google Scholar
• Westbrook C., Lin Y. -M., Jarabak J. NADP-linked 15-hydroxyprostaglandin dehydrogenase from human placenta: partial purification and characterization of the enzyme and identification of an inhibitor in placental tissue. Biochem. Biophys. Res. Commun. 1977; 76: 943
   PubMed Web of Science ®Google Scholar
• Lin Y. -M., Jarabak J. Isolation of two proteins with 9-keto-prostaglandin reductase and NADP-linked 15-hydroxyprostaglandin dehydrogenase activities and studies on their inhibition, Biochem. Biophys. Res. Commun. 1978; 81: 1227
   PubMed Web of Science ®Google Scholar
• Hassid A., Levine L. Multiple molecular forms of prostaglandin 15-hydroxydehydrogenase and 9-ketoreductase in chicken kidney. Prostaglandins 1977; 13: 503
   PubMedGoogle Scholar
• Wermuth B. Purification and properties of a NADPH-dependent carbonyl reductase from human brain. J. Biol. Chem. 1981; 256: 1206
   PubMed Web of Science ®Google Scholar
• Chang D. G.-B, Tai H. -H. Prostaglandin 9-ketoreductase/typell 15-hydroxyprostaglandin dehydrogenase is not a prostaglandin specific enzyme. Biochem. Biophys. Res. Commun. 1981; 101: 898
   PubMed Web of Science ®Google Scholar
• Jarabak J., Luncsford A., Berkantz D. Substrate specificity of three prostaglandin dehydrogenases. Prostaglandins 1983; 26: 849
   PubMed Web of Science ®Google Scholar
• Chung H., Harvey R. G., Armstrong R. N., Jarabak J. Polycyclic aromatic hydrocarbon quinones and glutathione thioethers as substrates and inhibitors of the human placental NADP-linked 15-hydroxyprostaglandin dehydrogenase. J. Biol. Chem. 1987; 262: 12, 448
   Google Scholar
• Chung H., Fried J., Williams-Ashman E., Jarabak J. Glutathione mixed disulfide inhibitors of the human placental NADP-linked 15-hydroxyprostaglandin dehydrogenase. Prostaglandins 1987; 33: 383
   PubMedGoogle Scholar
• Jarabak J. Polycyclic aromatic hydrocarbon qui-none-mediated oxidation reduction cycling catalyzed by a human placental NADPH-linked carbonyl reductase. Arch. Biochem. Biophys. 1991; 291: 334
   PubMed Web of Science ®Google Scholar
• Hinson J. A., Kadlubar F. F. Glutathione transferase in the detoxification of drug and carcinogen metabolites, in. Glutathione Conjugation. Mechanisms and Biological Significance, H. Sies, B. Ketterer. Academic Press, New York 1988; 236
   Google Scholar
• Wolf C. R., Lewis A. D., Carmichael J., Ansell J., Adams D. J., Hickson I. J., Harris A., Balkwill F. R., Hayes J. D. Glutathione. S, T. J. Mantle, C. B. Pickett, J. D. Hayes. Taylor and Francis, London 1987; 199, transferase expression in normal and tumor cells resistant to cytotoxic drugs, inGlutathione S-Transferase and Carcinogenesis
   Google Scholar
• Lewis A. D., Hayes J. D., Wolf C. R. Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effects. Carcinogenesis 1988; 9: 1283
   PubMed Web of Science ®Google Scholar
• Hayes J. D., Pickett C. B., Mantle T. J. Glutathione S-Transferases and Drug Resistance. Taylor and Francis, London 1990
   Google Scholar
• Motoyama N., Kulkarni A. P., Hodgson E., Dauterman W. C. Endogenous inhibitors of glutathione 5-transferases in house flies. Pestic. Biochem. Physiol. 1978; 9: 255
   Google Scholar
• Dierickx P. J. Interaction of benzo- and naphthoquinones with soluble glutathioneS-transferases from rat liver. Pharmacol. Res. Commun. 1983; 15: 581
   PubMedGoogle Scholar
• Vos R. M. E., van Ommen B., Hoekstein M. S. J., de Goede J. H. M., van Bladeren P. J. Irreversible inhibition of rat hepatic glutathioneS-transferase isoenzymes by a series of structurally related quinones. Chem. Biol. Int. 1989; 71: 381
   PubMed Web of Science ®Google Scholar
• van Ommen B., Den Besten C., Rutten A. C. M., Ploemen J. H. T. M., Vos R. M. E., Muller M., van Bladeren P. J. Active site-directed irreversible inhibition of glutathioneS-transferases by the glutathione conjugate of tetrachloro-1, 4-benzoquinone. J. Biol. Chem. 1988; 263: 12, 939
   Google Scholar
• van Ommen B., Ploemen J. H. T. M., Ruven H. J., Vos R. M. E., Bogaards J. J. P., van Berkel W. J. H., van Bladeren P. J. Studies on the active site of rat glutathioneS-transferase isoenzyme 4–4. Chemical modification by tetrachloro-1, 4-benzoquinone and its glutathione conjugate. Eur. J. Biochem. 1989; 181: 423
   PubMedGoogle Scholar
• van Ommen B., Ploemen J. P., Bogaards J. J. P., Monks T. J., Lau S. S., van Bladeren P. J. Irreversible inhibition of rat glutathione 5-transferase 1–1 by quinones and their glutathione conjugates: structure-activity relationship and mechanism. Biochem, J. 1991; 276: 661
   PubMed Web of Science ®Google Scholar
• Kiese M. Methemoglobinemia: A Comprehensive Treatise. CRC Press, Boca Raton, FL 1974
   Google Scholar
• Eyer P., Kiese M. Biotransformation of 4-dimethylaminophenol: reaction with glutathione, and some properties of the reaction products. Chem. Biol. Int. 1976; 14: 165
   PubMed Web of Science ®Google Scholar
• Kiese M., Szinicz L., Thiel N., Weger N. Ferrihemoglobin and kidney lesions in rats produced by 4-aminophenol or 4-dimethylaminophenol. Arch. Toxicol. 1975; 34: 337
   PubMed Web of Science ®Google Scholar
• Szinicz L. L., Weger N. Effects of 4-dimethylaminophenol in rat kidneys, isolated kidney tubules and hepatocytes. Xenobiotica 1980; 10: 611
   PubMed Web of Science ®Google Scholar
• Monks T. J., Lau S. S., Highet R. J., Gillette J. R. Glutathione conjugates of 2-bromohydroquinone are nephrotoxic. Drug Metab. Dispos. 1985; 13: 553
   PubMed Web of Science ®Google Scholar
• Monks T. J., Highet R. J., Lau S. S. 2-Bromo-(diglutathion-S-yl) hydroquinone nephrotoxicity: physiological, biochemical and electrochemical determinants. Mol. Pharmacol. 1988; 34: 492
   PubMed Web of Science ®Google Scholar
• Lau S. S., Hill B. A., Highet R. J., Monks T. J. Sequential oxidation and glutathione addition to 1, 4-benzoquinone: correlation of toxicity with increased glutathione substitution. Mol. Pharmacol. 1988; 34: 829
   PubMed Web of Science ®Google Scholar
• Mertens J. J. W. M., Temmink J. H. M., van Bladeren P. J., Jones T. W., Lo H. -H., Lau S. S., Monks T. J. Inhibition of γ-glutamyl transferase potentiates the nephrotoxicity of glutathione conjugated chlorohydroquinones. Toxicol. Appl. Pharmacol 1991; 110: 45
   PubMed Web of Science ®Google Scholar
• Lau S. S., Jones T. W., Highet R. J., Hill B. A., Monks T. J. Differences in the localization and extent of the renal proximal tubular necrosis caused by mercapturic acid and glutathione conjugates of menadione and 1, 4-naphthoquinone. Toxicol. Appl. Pharmacol. 1990; 104: 334
   PubMed Web of Science ®Google Scholar
• Tateshi M., Suzuki S., Shimizu H. Cysteine conjugate b˜-lyase in rat liver. A novel enzyme catalyzing formation of thiol-containing metabolites of drugs. J. Biol. Chem. 1978; 253: 8854
   PubMedGoogle Scholar
• Jakoby W. B., Stevens J., Duffel M. W., Weisiger R. A. The terminal enzymes of mercapturate formation and the thiomethyl shunt. Rev. Biochem. Toxicol. 1985; 6: 97
   Google Scholar
• Lock E. A. The nephrotoxicity of haloalkane and haloalkene glutathione conjugates in. Selectivity and Molecular Mechanisms of Toxicity, F. DeMattes, E. A. Lock. Macmillan. 1987; 59, New York
   Google Scholar
• Lock E. A. Studies on the mechanism of nephrotoxicity and nephrocarcinogenicity of halogenated alkenes. Crit. Rev. Toxicol. 1988; 19: 23
   PubMed Web of Science ®Google Scholar
• Anders M. W., Lash L. H., Dekant W., Elfarra A. A., Dohn D. R. Biosynthesis and biotransformation of glutathioneS-conjugates to toxic metabolites. Crit. Rev. Toxicol. 1988; 18: 311
   PubMed Web of Science ®Google Scholar
• Dekant W., Vamvakas S., Anders M. W. Bioactivation of nephrotoxic haloalkenes by glutathione conjugation: formation of toxic and mutagenic intermediates by cysteine conjugate b˜-lyase. Drug Metab. Rev. 1989; 20: 43
   PubMed Web of Science ®Google Scholar
• Monks T. J., Highet R. J., Chu P. S., Lau S. S. Synthesis and nephrotoxicity of 6-bromo-2, 5-dihydroxythiophenol. Mol. Pharmacol. 1988; 34: 15
   PubMed Web of Science ®Google Scholar
• Lau S. S., Monks T. J. The invivo disposition of 2-bromo14C-hydroquinone and the effect of γ-glutamyl transpeptidase inhibition. Toxicol. Appl. Pharmacol. 1990; 103: 121
   PubMed Web of Science ®Google Scholar
• Monks T. J., Jones T. W., Hill B. A., Lau S. S. Nephrotoxicity of 2-bromo-(cystein-S-yl)hydroquinone and 2-bromo-(N-acetylcystein-S-yl)hydroquinone thioethers. Toxicol. Appl. Pharmacol. 1991; 111: 279
   PubMed Web of Science ®Google Scholar
• Monks T. J., Highet R. J., Lau S. S. Oxidative cyclization, 1, 4-benzothiazine formation and dimerization of 2-bromo-3-(glutathion-5-yl)hydro-quinone. Mol. Pharmacol. 1990; 38: 121
   PubMed Web of Science ®Google Scholar
• Prota G. Some new aspects of eumelanin chemistry. Prog. Clin. Biol. Med. 1988; 256: 101
   PubMedGoogle Scholar
• Redegeld F. A. M., Hofman G. A., van der Loo P. G. F., Koster A. S., Noordhoek J. Nephrotoxicity of the GSH conjugate of menadione (2-methyl-1,4-naphthoquinone) in the isolated perfused rat kidney. Role of metabolism by γ-Glutamyl transpeptidase and probenecid-sensitive transport. J. Pharmacol. Exp. Ther. 1989; 256: 665
   Web of Science ®Google Scholar
• Nakai N., Hase. J. Chem. Pharm. Bull. 1968; 16: 2334
   Google Scholar
• Green C. R., Ham K. N., Tange J. D. Kidney lesions induced in rats by 4-aminophenol. Br. Med. J. 1969; 1: 162
   PubMed Web of Science ®Google Scholar
• Newton J. F., Kuo C. -H., Gemborys M. W., Mudge G. H., Hook J. B. Nephrotoxicity of 4-aminophenol, a metabolite of acetaminophen in the F344 rat. Toxicol. Appl. Pharmacol. 1982; 65: 336
   PubMed Web of Science ®Google Scholar
• Eckert K. -G., Eyer P., Sonnenbichler J., Zetl I. Activation and detoxication of aminophenols. II. Synthesis and structural elucidation of various thiol addition products of 1,4-benzoquinoneimine andN-acetyl-1,4-benzoquinoneimine. Xenobiotica 1990; 20: 333
   PubMed Web of Science ®Google Scholar
• Gartland K. P. R., Bonner F. W., Timbrell J. A., Nicholson J. K. Biochemical characterization of 4-aminophenol-induced nephrotoxic lesions in the F344 rat. Arch. Toxicol. 1989; 63: 97
   PubMed Web of Science ®Google Scholar
• Fowler L. M., Moore R. D., Foster J. R., Lock E. A. Nephrotoxicity of 4-aminophenol glutathione conjugate. Hum. Exp. Toxicol. 1991; 10: 451
   PubMed Web of Science ®Google Scholar
• Klos C., Koob M., Kramer C., Dekant W. p-Aminophenol nephrotoxicity: biosynthesis of toxic glutathione conjugates. Toxicol. Appl. Pharmacol. 1992; 115: 98
   PubMed Web of Science ®Google Scholar
• Kari F. W. Toxicology and carcinogenesis studies of hydroquinone in F344/N rats and B6C3F1 mice (gavage studies) National Toxicology Program Technical Report, 366, U. S. Department of Health and Human Services, PHS, NIH. 1989
   Google Scholar
• Shibata M. -A., Hirose M., Tanaka H., Asakawa E., Shirai T., Ito N. Induction of renal cell tumors in rats and mice, and enhancement of hepatocellular tumor development in mice after long-term hydroquinone treatment. Jpn. J. Cancer Res. 1991; 82: 1211
   PubMedGoogle Scholar
• Tunek A., Piatt K. L., Przybylski M., Oesch F. Multi-step metabolic activation of benzene. Effect of superoxide dismutase on covalent binding to microsomal macromolecules, and identification of glutathione conjugates using high pressure liquid chromatography and field desorption mass spectrometry. Chem. Biol. Int. 1980; 33: 1
   PubMed Web of Science ®Google Scholar
• Lunte S. M., Kissinger P. T. Detection and identification of sulfhydryl conjugates of. p. 1983; 195, benzoquinone in microsomal incubations of benzene and phenol, Chem. Biol. Int., Al
   Google Scholar
• Sawahata T., Neal R. A. Biotransformation of phenol to hydroquinone and catechol by rat liver microsomes. Mol. Pharmacol. 1983; 23: 453
   PubMed Web of Science ®Google Scholar
• Eckert K. -G., Eyer P., Sonnenbichler J., Zetl I. Activation and detoxication of aminophenols. III. Synthesis and structural elucidation of various glutathione addition products to 1,4-benzoquinone. Xenobiotica 1990; 20: 351
   PubMed Web of Science ®Google Scholar
• Nerland D. E., Pierce W. M. Identification ofN-acetyl-S-(2,5-dihydroxyprienyl)-L-cysteine as a urinary metabolite of benzene, phenol, and hydroquinone. Drug Metab. Dispos. 1990; 18: 958
   PubMed Web of Science ®Google Scholar
• Tajima K., Hashizaki M., Yamamoto K., Mizutani T. Identification and structure characterization of S-containing metabolites of 3-tert-butyl-4-hydroxyanisole in rat urine and liver microsomes. Drug Metab. Dispos. 1991; 19: 1028
   PubMed Web of Science ®Google Scholar
• Tsuda H., Fukushima S., Imaida K., Sakata T., Ito N. Modification of carcinogenesis by antioxidants and other compounds. Acta Pharmacol. Toxicol. 1984; 55: 125
   PubMedGoogle Scholar
• Li J. J., Li S. A., Klicka J. K., Parson J. A., Lam L. K. T. Relative carcinogenic activity of various synthetic and natural estrogens in the hamster kidney. Cancer Res. 1983; 43: 5200
   PubMed Web of Science ®Google Scholar
• Li S. A., Klicka J. K., Li J. J. Estrogen 2–4-hydroxylase activity and catechol estrogen formation in the hamster kidney: implications for estrogen carcinogenesis. Cancer Res. 1985; 45: 181
   PubMed Web of Science ®Google Scholar
• Liehr J. G. 2-Fluoroestradiol: separation of estrogenicity from carcinogenicity. Mol. Pharmacol. 1983; 23: 278
   PubMed Web of Science ®Google Scholar
• Marks F., Hecker E. Metabolism and mechanism of action of estrogens. XII. Structure and mechanism of formation of water-soluble and protein-bound metabolites of estrone in rat liver microsomes in vitro and in vivo. Biochem. Biophys. Acta 1969; 187: 250
   PubMed Web of Science ®Google Scholar
• Kuss E. Water-soluble metabolites of oestradiol-17b˜. III. Separation and identification of 1- and 4-glutathione thioethers of 2,3-dihydroxy-oestratrienes. Hoppe-Seylers, Z. Physiol. Chem. 1969; 350: 95
   PubMedGoogle Scholar
• Kuss E. Microsomal oxidation of estradiol-17b˜. 2-Hydroxylation and 1- or 4-thioether formation with and without 17-hydroxyl dehydrogenation. Hoppe-Seylers, Z. Physiol. Chem. 1971; 352: 817
   PubMedGoogle Scholar
• Hoppen H. -O., Siekmann L., Breuer H. Metabolism of oestrone in the microsomal fraction of rat liver. Hoppe-Seylers Z. Physiol. Chem. 1974; 355: 1304
   Google Scholar
• Elce J. S. Metabolism of a glutathione conjugate of 2-hydroxyoestradiol by rat liver and kidney preparations. in vitro, Biochem. J. 1970; 116: 913
   PubMedGoogle Scholar
• Elce J. S. Metabolism of a glutathione conjugate of 2-hydroxyoestradiol-17B in the adult male rat. Biochem. J. 1972; 126: 1067
   PubMed Web of Science ®Google Scholar
• Elce J. S., Harris J. Conjugation of 2-hydroxy-estradiol-17b˜ [1,3,5 (10)-estratriene-2,3, 17b˜-triol] with glutathione in the rat. Steroids 1971; 18: 583
   PubMed Web of Science ®Google Scholar
• Elce J. S., Chandra J. Estrogen mercapturic acid in the adult male rat. Steroids 1973; 22: 699
   PubMedGoogle Scholar
• Ball P., Haupt M., Knuppen R. Biogenesis and metabolism of catechol estrogens. in vitro, in Catechol Estrogens, G. R. Merriam, M. B. Lip-Sett. Raven Press, New York 1983; 91, Eds
   Google Scholar
• Tannebaum M. Ultrastructural pathology of human renal cell tumors. Pathol. Ann. 1971; 6: 249
   Google Scholar
• deKernion J. B. Campbell's Urology, 5th ed., P. C. Welsh, et al. W. B. Saunders, Philadelphia 1986; 1294
   Google Scholar
• Gonzalez A., Oberley T. O., Li J. J. Morphological and immunohistochemical studies of the estrogen-induced Syrian hamster renal tumor: probable cell of origin. Cancer Res. 1989; 49: 1020
   PubMed Web of Science ®Google Scholar
• Ross D., Larsson R., Norbeck K., Ryhage R., Moldeus P. Characterization and mechanism of formation of reactive products formed during peroxidase-catalysed oxidation ofp-phenetidine. Mol. Pharmacol. 1985; 27: 277
   PubMed Web of Science ®Google Scholar
• Andersson B., Larsson R., Rahimtula A., Moldeus P. Hydroperoxide-dependent activation ofp-phenetidine catalyzed by prostaglandin synthase and other peroxidases. Biochem. Pharmacol. 1983; 32: 1045
   PubMed Web of Science ®Google Scholar
• Andersson B. R., Larsson A., Rahimtula A., Moldeus P. Prostaglandin synthase and horseradish peroxidase catalysed DNA binding of p-phenetidine. Carcinogenesis 1984; 5: 161
   PubMedGoogle Scholar
• Larsson R., Boutin J., Moldeus P. Peroxidase-catalysed metabolic activation of xenobiotics in. Metabolism of Xenobiotics, J. W. Gorrod, H. Oelschlager, J. Caldwell. Taylor and Francis, New York 1988; 43
   Google Scholar
• Kriz W., Kaissling B. Structural organization of the mammalian kidney, in. The Kidney: Physiology and Pathophysiology, D. N. Seldin, G. Giebisch. Raven Press, New York 1985; 265
   Google Scholar
• Tate S. S. Enzymes of mercapturic acid formation, in. Enzymatic Basis of Detoxication, W. B. Jacoby. Academic Press, New York 1980; 95
   Google Scholar
• Lau S. S., Jones T. W., Sioco R., Hill B. A., Pinon R. K., Monks T. J. Species differences in renal γ-glutamyl transpeptidase do not correlate with susceptibility to 2-bromo-(diglutathion-S-yl)hydroquinone nephrotoxicity. Toxicology 1990; 64: 291
   PubMed Web of Science ®Google Scholar
• Yamashita K., Totani K., Iwaki Y., Takamisawa I., Tateishi N., Higashi T., Sakamoto Y., Kobata A. Comparative study of the sugar chains of γ-glutamyl-transpeptidases purified from human hepatocellular carcinoma and from human liver. J. Biochem. 1989; 105: 728
   PubMed Web of Science ®Google Scholar
• Rajpert-Demeyts E., Heisterkamp N., Groffen J. Cloning and nucleotide sequence of human γ-Glutamyl transpeptidase. Proc. Natl. Acad. Sci. U. S. A. 1988; 85: 8840
   PubMedGoogle Scholar
• Pawlak A., Lahuna O., Bulle F., Suzuki A., Ferry N., Siegrist S., Chikhi N., Chobert M. N., Guellaen G., Laperche Y. γ-Glutamyl transpeptidase: a single copy gene in the rat and a multigene family in the human genome. J. Biol. Chem. 1988; 263: 9913
   PubMedGoogle Scholar
• Reyes E. Rat brain γ-Glutamyltranspeptidase: effects of alcohol. Res. Commun. Chem. Pathol. Pharmacol. 1978; 21: 145
   PubMedGoogle Scholar
• Reyes E., Barela T. D. Isolation and purification of multiple forms of γ-Glutamyl transpeptidase from rat brain. Neurochem. Res. 1980; 5: 159
   PubMedGoogle Scholar
• Antoine B., Visvikis A., Thioudellet C., Rahimi-Pour A., Strazielle N., Wellman M., Siest G. Electrophoretic mobility of γ-glutamyltransferase in rat liver subcellular fractions. Evidence for structure difference from the kidney enzyme. Biochem. J. 1989; 262: 535
   PubMedGoogle Scholar
• Meister A., Tate S. S., Ross L. L. Membrane-bound γ-glutamyl transpeptidase, in. The Enzymes of Biological Membranes, A. Martonosi. Plenum, New York 1976; 315
   Google Scholar
• Augusteyn R. C. Protein modification of cataract: possible oxidative mechanisms, in. Mechanisms of Cataract Formation in the Human Lens, G. Duncan. Academic Press, London 1981; 71
   Google Scholar
• Spector A. Towards a solution of senile cataracts. Invest. Opthamol. Vis. Sci. 1984; 25: 130
   PubMed Web of Science ®Google Scholar
• Pethig R., Gascoyne P. R. C., McLaughlin J. A., Szent-Gyorgi A. Ascorbate-quinone interactions: electrochemical, free radical, and cytotoxic properties. Proc. Natl. Acad. Sci. U. S. A. 1983; 80: 129
   PubMed Web of Science ®Google Scholar
• Wolff S. P., Spector A. Pro-oxidant activation of ocular reductants. II. Lens epithelial cell cytotoxicity of a dietary quinone is associated with a stable free radical formed with glutathione in vitro. Exp. Eye Res. 1987; 45: 791
   PubMed Web of Science ®Google Scholar
• Takahashi N., Schreiber J., Fischer V., Mason R. Formation of glutathione-conjugated semiquinones by the reaction of quinones with glutathione; an ESR study. Arch. Biochem. Biophys. 1987; 252: 41
   PubMed Web of Science ®Google Scholar
• Rao D. N. R., Takahashi N., Mason R. P. Characterization of a glutathione conjugate of the 1,4-benzosemiquinone-free radical formed in rat hepatocytes. J. Biol. Chem. 1988; 263: 17, 981
   PubMedGoogle Scholar
• Rees J. R., Pirie A. Possible reactions of 1, 2-naphthoquinone in the eye. Biochem. J. 1967; 102: 853
   PubMed Web of Science ®Google Scholar
• Wells P. G., Wilson B., Lubek B. M. In vivo studies on the biochemical mechanism of naphthalene cataractogenesis. Toxicol. Appl. Pharmacol. 1989; 99: 466
   PubMed Web of Science ®Google Scholar
• Hinson J. A., Monks T. J., Highet R. J., Hong M., Pohl L. R. 3-(Glutathion-S-yl) acetaminophen. A biliary metabolite of acetaminophen. Drug Metab. Dispos. 1982; 10: 47
   PubMed Web of Science ®Google Scholar
• Rosen G. M., Rauckman E. J., Ellington S. P., Dahlin D. C., Christie J. L., Nelson S. D. Reduction and glutathione conjugation reaction ofN-acetyl-p-benzoquinone imine and two dimethylated analogues. Mol. Pharmacol., 25: 151, 1984
   PubMedGoogle Scholar
• Shichi H., Gaasterland D., Jensen N. M., Nebert D. W. Ah locus: genetic differences in susceptibility to cataracts induced by acetaminophen. Science 1978; 200: 539
   PubMed Web of Science ®Google Scholar
• Shichi H., Tanaka M., Jensen N. M., Nebert D. W. Genetic differences in cataract and other ocular abnormalities induced by paracetamol and naphthalene. Pharmacology 1980; 20: 229
   PubMed Web of Science ®Google Scholar
• Lubek B. M., Avaria M., Basu P. K., Wells P. G. Pharmacological studies on thein vivo catar-actogenicity of acetaminophen in mice and rabbits. Fund. Appl. Toxicol. 1988; 10: 596
   PubMedGoogle Scholar
• Lubek B. M., Basu P. K., Wells P. G. Metabolic evidence for the involvement of enzymatic bioactivation in the cataractogenicity of acetaminophen in genetically susceptible (C57BL/6) and resistant (DBA/2) murine strains. Toxicol. Appl. Pharmacol. 1988; 94: 487
   PubMed Web of Science ®Google Scholar
• Orlowski M., Sessa G., Green J. P. γ-Glutamyl transpeptidase in brain capillaries: possible site of a blood-brain barrier for amino acids. Science 1974; 184: 184
   Google Scholar
• Djuricic B. M., Mrsulja B. B. Enzymatic activity of the brain: microvessels vs. total forebrain homogenate. Brain Res. 1977; 138: 561
   PubMedGoogle Scholar
• DeBault L., Cancilla P. A. γ-Glutamyl transpeptidase in isolated brain endothelial cells: induction by glial cells. in vitro, Science 1980; 207: 653
   Google Scholar
• Shine H. D., Haber B. Immunocytochemical localization of γ-glutamyl transpeptidase in the rat CNS. Brain Res. 1981; 217: 339
   PubMedGoogle Scholar
• Varga V., Somogyi J., Langley O. K., et al. Localization of γ-Glutamyl transpeptidase in neural tissue, in. Gamma-Glutamyltransferases: Advances in Biochemical Pharmacology, G. Siest, C. Heusghem. Masson, Paris 1982; 31
   Google Scholar
• Baranczyk-Kuzma A., Audus K. L., Borchardt R. T. Catecholamine metabolizing enzymes of bovine brain microvessel endothelial cell monolayers. J. Neurochem. 1986; 46: 1956
   PubMed Web of Science ®Google Scholar
• Minn A., Besagni D. Uptake of L-glutamine into synaptosomes. Is the γ-glutanyl cycle involved?. Life Sci. 1983; 33: 619
   PubMedGoogle Scholar
• Ghersi-Egea J. F., Minn A., Seist G. Changes of cerebral gamma-glutamyl-transferase activities after treatment with exogenous inducers. Neurochem. Res. 1987; 12: 357
   PubMedGoogle Scholar
• Wakamatsu K., Ito S., Nagatsu T. Cys-teinyldopamine is not incorporated into neurome-lanin. Neurosci. Lett. 1991; 131: 57
   PubMedGoogle Scholar
• Wooley D. W., Shaw E. A biochemical and pharmacological suggestion about certain mental disorders. Proc. Natl. Acad. Sci. U. S. A. 1954; 40: 228
   PubMed Web of Science ®Google Scholar
• Gaddum J. H. Tryptamine receptors. J. Physiol. (London) 1953; 119: 363
   Google Scholar
• McLsaac W. M., Page I. H. The metabolism of serotonin (5-hydroxytryptamine). J. Biol. Chem. 1959; 234: 858
   PubMedGoogle Scholar
• Ericksen N., Martin G. M., Benditt E. P. Oxidation of the indole nucleus of 5-hydroxytryptamine and the formation of pigments: isolation and partial characterization of a dimer of 5-hydroxytryptamine. J. Biol. Chem. 1960; 235: 1662
   PubMedGoogle Scholar
• Baumgarten H. G., Bjorklund A., Lachenmayer L., Nobin A., Stenevi U. Long-lasting selective depletion of brain serotonin by 5,6-dihydrox-ytryptamine. Acta Physiol. Scand. 1971; 66: 1
   Google Scholar
• Baumgarten H. G., Evetts K. D., Holman R. B., Iverson L. L., Vogt M., Wilson G. Effects of 5,6-dihydroxytryptamine on monoaminergic neurones in the central nervous system of the rat. J. Neurochem. 1972; 19: 1587
   PubMed Web of Science ®Google Scholar
• Baumgarten H. G., Goethert M., Holstein A. F., Schlossberger H. G. Chemical sympathectomy induced by 5,6-dihydroxytryptamine. Z. Zellforsch. 1972; 128: 115
   PubMedGoogle Scholar
• Perry E. K., Marshall E. F., Blessed G. Decreased imipramine binding in the brains of patients with depressive illness. Br. J. Psychiatry 1983; 142: 188
   PubMed Web of Science ®Google Scholar
• Bowen D. M., Allen S. J., Benton J. S., Goodhardt M. J., Haan M. J., Palmer A. M., Sims N. R., Smith C. C. T., Spillane J. A., Esiri M. M., Neary D., Snowden J. S., Wilcock G. K., Davison A. N. Biochemical assesment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. J. Neurochem. 1983; 41: 266
   PubMed Web of Science ®Google Scholar
• Palmer A. M., Francis P. T., Benton J. S., Sims N. R., Mann D. M. A., Neary D., Snowden J. S., Bowen D. M. Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. J. Neurochem. 1987; 48: 8
   PubMed Web of Science ®Google Scholar
• Volicer L., Langlais P. J., Matson W. R., Mark K. A., Gamache P. H. Serotoninergic system in dementia of the Alzheimer type. Abnormal forms of 5-hydroxytryptophan and serotonin in cerebrospinal fluid. Arch. Neurol. 1985; 42: 1158
   PubMedGoogle Scholar
• Matson W. R., Langlais P., Volicer L., Gamache P. H., Bird E., Mark K. A. n-Electrode three-dimensional chromatography with electrochemical detection for determination of neurotransmitters. Clin. Chem. 1984; 30: 1477
   PubMed Web of Science ®Google Scholar
• Chen J. -C, Crino P. B., Schnepper P. W., To A. C. S., Volicer L. Increased serotonin efflux by a partially oxidized serotonin: tryptamine-4,5-dione. J. Pharmacol. Exp. Ther. 1989; 250: 141
   PubMedGoogle Scholar
• Wolf W. A., Bobik A. Effects of 5,6-dihydroxytryptamine on the release, synthesis and storage of serotonin: studies using rat brain synaptosomes. J. Neurochem. 1988; 50: 534
   PubMedGoogle Scholar
• Slivka A., Spina M. B., Cohen G. Reduced and oxidized glutathione in human and monkey brain. Neurosci. Lett. 1987; 74: 112
   PubMed Web of Science ®Google Scholar
• Wong K. -S., Dryhurst G. Tryptamine-4, 5-dione: properties and reaction with glutathione. Bioorg. Chem. 1990; 18: 253
   Web of Science ®Google Scholar
• Singh S., Dryhurst G. Reactions of the serotonergic neurotoxin 5,6-dihydroxy-tryptamine with glutathione. J. Org. Chem. 1991; 56: 1767
   Google Scholar
• Zhang F., Dryhurst G. Electrochemical and enzyme-mediated oxidation of tetrahydropapavero-line. J. Org. Chem. 1991; 56: 7113
   Google Scholar
• Fa Z., Dryhurst G. Interactions of salsolinol with oxidative enzymes. Biochem. Pharmacol. 1991; 42: 2209
   PubMedGoogle Scholar
• Fa A., Dryhurst G. Oxidation chemistry of the endogenous central nervous system alkaloid salsolinol. I. Electrochemical studies. Bioorg. Chem. 1991; 19: 384
   Google Scholar
• Wahley M. W., Govindachari T. R. The Pictet-Spengler synthesis of tetrahydroisoquinolines and related compounds. Org. React. 1951; 6: 151
   Google Scholar
• Sjoquist B., Liljequist S., Engel J. Increased salsolinol levels in rat striatum and limbic forebrain following chronic ethanol treatment. J. Neurochem. 1982; 39: 259
   PubMedGoogle Scholar
• Myers W. D., Mackenzie L., Ng K. T., Singer G., Smythe G. A., Duncan M. W. Salsolinol and dopamine in rat medial basal hypothalamus after chronic ethanol exposure. Life Sci. 1984; 36: 309
   Google Scholar
• Matsubara K., Fukishima S., Fukui Y. A systematic regional study of brain salsolinol levels during and immediately following chronic ethanol injection in rats. Brain Res. 1987; 413: 336
   PubMedGoogle Scholar
• Collins M. A., Nijm W. P., Borge G., Teas G., Goldfarb C. Dopamine-related tetrahydroiso-quinolines: significant urinary excretion by alcoholics after alcohol consumption. Science 1979; 206: 1184
   PubMed Web of Science ®Google Scholar
• Sjoquist B., Borg S., Kvande H. Catecholamine derived compounds in urine and cerebrospinal fluid from alcoholics during and after longstanding intoxication. Subst. Alcohol Actions/Misuse 1981; 7: 63
   Google Scholar
• Cohen G., Collins M. A. Alkaloids from catecholamines in adrenal tissue: possible role in addiction. Science 1970; 167: 1749
   PubMed Web of Science ®Google Scholar
• Collins M. A. A possible neurochemical mechanism for brain and nerve damage associated with chronic alcoholism. Trends Pharmacol. Sci. 1982; 3: 373
   Web of Science ®Google Scholar
• Davis V. E., Walsh M. J. Alcohol, amines and alkaloids: a possible biochemical basis for alcohol addiction. Science 1970; 167: 1005
   PubMed Web of Science ®Google Scholar
• Myers R. D., Melchior C. L. Alcohol drinking: abnormal intake caused by tetrahydropapavero-line in brain. Science 1977; 196: 554
   PubMed Web of Science ®Google Scholar
• Lin L. Y., Kumagai Y., Cho A. K. Enzymatic and chemical demethylenation of (mefhylenedioxy)amphetamine and (methylenedioxy) meth-amphetamine by rat brain microsomes. Chem. Res. Toxicol. 1992; 5: 401
   PubMed Web of Science ®Google Scholar
• Fukuto J. M., Kumagai Y., Cho A. K. Determination of the mechanism of demethylenation of (methylenedioxy)phenyl compounds by cytochrome P450 using deuterium isotope effects. J. Med. Chem. 1991; 34: 2871
   PubMed Web of Science ®Google Scholar
• Johnson M., Elayan I., Hanson G. R., Foltz R. L., Gibb J. W., Lim H. K. Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihy-droxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems. J. Pharm. Exp. Ther. 1992; 261: 447
   PubMedGoogle Scholar
• Patel N., Kumagai Y., Unger S. E., Fukuto J. M., Cho A. K. Transformation of dopamine and a-methyldopamine by NE 108–15 cells: formation of thiol adducts. Chem. Res. Toxicol. 1991; 4: 421
   PubMedGoogle Scholar
• Hiramatsu M., Kumagai Y., Unger S. E., Cho A. K. Metabolism of methylene-dioxy-methamphetamine: formation of dihydroxymetham-phetamine and a quinone identified as its glutathione adduct. J. Pharm. Exp. Ther. 1990; 254: 521
   PubMed Web of Science ®Google Scholar
• Singleton V. L., Zaya J., Trousdale E., Salgues M. Caftaric acid in grapes and conversion to a reaction product during processing. Vitis 1984; 23: 113
   Web of Science ®Google Scholar
• Singleton V. L., Salgues M., Zaya J., Trousdale E. Disappearance and conversion to products of enzymatic oxidation in grape must and wine. Am. J. Enol. Vine 1985; 36: 50
   Web of Science ®Google Scholar